Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus - Wikidata - wikimedia - TriplyDB

Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus

Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus

http://www.wikidata.org/entity/Q40903164

about

Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections.Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.Prosthetic joint infection: diagnosis and management.Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Drug treatments for prosthetic joint infections in the era of multidrug resistance.Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.Synergistic effect of a novel focal hyperthermia on the efficacy of rifampin in staphylococcal experimental foreign-body infection.Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance.Safety of prolonged high-dose levofloxacin therapy for bone infections.FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis.Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An in Vivo Study With an Experimental Model of Foreign-Body Infection.Spinal infection multidisciplinary management project (SIMP): from diagnosis to treatment guideline

P2860

Q34309608-C6386BC2-2AA6-4145-8425-ED6C1290F12B Q34596619-E9A9E8AC-6EFA-476A-A3A3-4FF5CB0C8441 Q35083990-D3CCE26D-6810-43EB-8820-469BE6AA51FD Q35806369-E4822ED9-738D-4F1D-A9CC-F91B5DEB72A5 Q37115701-C9F9387A-08F9-463C-A2B2-67069DF1A6AA Q37144883-93239A47-D77C-4107-8615-AE3678B88149 Q37615927-0CC271B8-529F-4C52-AABD-B58C58B6BB47 Q37929757-A5CFDD5F-1121-4564-84CE-1FCFC5EA7804 Q38089918-1B9B1B26-BC1D-4567-A86C-FD04E103298C Q38314400-8FC73A8A-08CE-404E-BFC7-2599092B6F83 Q38800556-7859D1B1-1164-4415-A24E-6C402C7016EE Q38823701-FA6FE662-252F-4993-8B33-D4777B73E868 Q39352419-5524B0A0-2B62-4F06-A8C7-B9A8CF747C04 Q40536868-BE812FC6-D2A1-4078-98BE-DE01EFC7AFF3 Q41833286-F7DE668A-5D28-476F-BBFE-0493D9089BD3 Q41913615-33D14233-2878-4EA2-A3C5-3A114E44C111 Q42008069-A149EBC9-67E5-43EC-89AE-5439F809ACAA Q42036509-3F6E3DBF-024A-4478-82DA-3D5B67C8095A Q42209248-BF6045CA-D951-4166-A0CE-8D694F7C06B3 Q42529961-DCBE4594-6147-47A5-97B8-09D50BB02A70 Q42586714-B1CB9148-6E06-4EC3-A0B3-47E16DAF2133 Q43169904-59773ED5-7425-4381-B303-36B0F55AC7DA Q43275288-904B5483-B83F-4304-8085-5BEFC5ACF4F3 Q43278333-4727DD13-AC2A-47F1-BD3A-F4A368C015B3 Q44848833-B4F219EA-3CA9-4697-9FAA-DC3B1ADAEBE9 Q46784450-840B86EF-33A0-4150-AEFF-BDE3091F884B Q53150915-42B87756-BDB1-4734-9677-2984F5FB016E Q55228263-2AF9A5BC-362F-40C2-9FDF-773FCC1EF1E1 Q56987059-79C32D4A-2088-4C7C-A8C2-163C00A20AA6

P2860

Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus

http://www.wikidata.org/entity/Q40903164

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Efficacy of high doses of levo ...... ceptible Staphylococcus aureus

@en

type

label

Efficacy of high doses of levo ...... ceptible Staphylococcus aureus

@en

prefLabel

Efficacy of high doses of levo ...... ceptible Staphylococcus aureus

@en

P1433

Q40903164-9CFA679F-BA7C-4FDB-A7F9-D5DA7480D00D

P1476

Q40903164-18CC2430-5C73-4B13-ADA2-A01116C8AEFA

P2093

Q40903164-02FAAE8F-A2AC-4C49-9309-4F3EDBC1614D

Q40903164-1E70D343-EC90-4775-9B70-EA549A4A155A

Q40903164-26DA552F-5D69-472C-8555-473C0BE5C763

Q40903164-48BF2249-AE05-466C-9DA6-56765F7C24A8

Q40903164-5CEA4E7B-D5AB-433F-B232-87A9F1308C36

Q40903164-7C97EA3D-56D6-4259-8832-0C6B4F9C2EA8

Q40903164-95A9CAD1-566E-4417-805D-3E4B3A04943D

P2860

Q40903164-0194ED35-1DEC-413E-8410-F1EC16068D00

Q40903164-032FB6F2-9984-4D38-86E9-E1AEAE7A1FE3

Q40903164-0347DAD7-D99F-4763-BD59-1AFD1C9351EB

Q40903164-07B1AF4B-A3C6-4E04-B0C9-CEA3FFB58D16

Q40903164-196CCE8C-2B88-48D6-B892-A758D2784D19

Q40903164-28AC8EB4-4D1E-44EF-8BC2-DAC345025512

Q40903164-291B264E-3235-4B59-94B0-9D6DC47D52C6

Q40903164-2B56C90B-956C-4F2A-A48D-DD3B4CC3A767

Q40903164-2BE78B74-B889-4BD5-9348-2F23E81E9259

Q40903164-2F97667E-B3AF-4F16-8D7B-B6D16E0BE17E

P304

Q40903164-B6BA9775-D85A-474A-914A-B2252270BE00

P31

Q40903164-F4A0BF29-04A7-4795-A368-5B5BB53824F2

P356

Q40903164-B27A2BA1-2BF9-46C5-9B63-919841E7FFD0

P407

Q40903164-10DF4A83-1DED-45EA-99FA-3DED13D6AFEA

P433

Q40903164-9F4C575C-5D4D-4A0C-BAF5-FEC88C9D4C38

P478

Q40903164-6E71AFC0-52CD-4049-8BD0-C047CB0C1531

P577

Q40903164-3A35CCB5-D37B-458A-A93B-4532368829C0

P698

Q40903164-BBCF41F1-7B8E-483E-B67A-4AF66D2CDE2F

P932

Q40903164-325211F4-54A7-4DBC-8655-C968FE1CE507

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of high doses of levo ...... ceptible Staphylococcus aureus

@en

P2093

A Doménech

http://www.w3.org/2001/XMLSchema#string

A Garcia

http://www.w3.org/2001/XMLSchema#string

C Cabellos

http://www.w3.org/2001/XMLSchema#string

F Gudiol

http://www.w3.org/2001/XMLSchema#string

F Tubau

http://www.w3.org/2001/XMLSchema#string

J Ariza

http://www.w3.org/2001/XMLSchema#string

O Murillo

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

Bacterial biofilms: a common cause of persistent infections

Antibiotic resistance of bacteria in biofilms

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.

Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.

Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

What have we learned from pharmacokinetic and pharmacodynamic theories?

Does the dose matter?

P304

4011-4017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00523-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17015630

http://www.w3.org/2001/XMLSchema#string

P932

1693998

http://www.w3.org/2001/XMLSchema#string